Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NWRN.SW

Price:

$7.71

Market Cap:

$164.04M

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.[Read more]

Industry

Biotechnology

IPO Date

2006-12-12

Stock Exchange

SIX

Ticker

NWRN.SW

The ROE as of September 2024 (TTM) for Newron Pharmaceuticals S.p.A. (NWRN.SW) is 63.79%

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 63.79%. This represents a change of -12.61% compared to the average of 72.99% of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Historical ROE (quarterly & annually)

How has NWRN.SW ROE performed in the past?

The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is -63.92%. The current 63.79% ROE has changed -199.80% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's ROE was at its highest in in the June 2022 quarter at 164.65%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.

Quarterly (TTM)
Annual

Average

-63.92%

Median

-32.56%

Minimum

-479.59%

Maximum

124.68%

Newron Pharmaceuticals S.p.A. (NWRN.SW) ROE by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 293.90%

Maximum Annual ROE = 124.68%

Minimum Annual Increase = -126.00%

Minimum Annual ROE = -479.59%

Quarterly (TTM)
Annual
YearROEChange
202354.25%-56.49%
2022124.68%-126.00%
2021-479.59%293.90%
2020-121.76%121.72%
2019-54.91%100.28%
2018-27.42%251.53%
2017-7.80%-74.54%
2016-30.63%-50.18%
2015-61.48%78.20%
2014-34.50%2.51%

Newron Pharmaceuticals S.p.A. (NWRN.SW) Average ROE

How has NWRN.SW ROE performed in the past?

The current ROE of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-100.22%

5-year avg

-95.47%

10-year avg

-63.92%

Newron Pharmaceuticals S.p.A. (NWRN.SW) ROE vs. Peers

How is NWRN.SW’s ROE compared to its peers?

Newron Pharmaceuticals S.p.A.’s ROE is less than Santhera Pharmaceuticals Holding AG (956.56%), greater than Basilea Pharmaceutica AG (-19.22%), greater than Addex Therapeutics Ltd (-456.77%), greater than Evolva Holding SA (-588.99%), less than Cosmo Pharmaceuticals N.V. (15.11%),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Newron Pharmaceuticals S.p.A.'s ROE?

How is the ROE calculated for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the highest ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 3-year average ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 5-year average ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

How does the current ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW) compare to its historical average?